Biocryst Pharmaceuticals (BCRX) Inventory Average (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Inventory Average came in at $5.7 million in Q1 2026, down 23.91% YoY from $7.5 million in Q1 2025, and up 7.08% on a QoQ basis from $5.3 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Inventory Average (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 13 years of Inventory Average data on file, last reported at $5.7 million in Q1 2026.
- Quarterly Inventory Average fell 23.91% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (down 23.91% YoY) and the FY2025 annual result came in at $6.7 million, down 63.33% from the prior year.
- Inventory Average rose to $5.7 million in Q1 2026, from $5.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $29.2 million in Q1 2024 to a low of $5.1 million in Q3 2025.
- A 5-year average of $17.1 million and a median of $17.1 million in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 156.63% — and 2024, when it tumbled 78.8%.
- Tracing BCRX's Inventory Average over 5 years: stood at $27.3 million in 2022, then climbed by 6.89% to $29.2 million in 2023, then sank by 73.16% to $7.8 million in 2024, then slumped by 32.07% to $5.3 million in 2025, then climbed by 7.08% to $5.7 million in 2026.
- The last three Inventory Average figures came in at $5.7 million (Q1 2026), $5.3 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 824.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.02 Mn |
| Mar 31, 2026 | 5.69 Mn |
| Dec 31, 2025 | 5.32 Mn |
| Sep 30, 2025 | 5.14 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 7.48 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Sep 30, 2024 | 6.01 Mn |
| Jun 30, 2024 | 17.12 Mn |
| Mar 31, 2024 | 29.23 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.33 Mn |
| Jun 30, 2023 | 27.25 Mn |
| Mar 31, 2023 | 27.50 Mn |
| Dec 31, 2022 | 27.28 Mn |
| Sep 30, 2022 | 25.20 Mn |
| Jun 30, 2022 | 19.89 Mn |
| Mar 31, 2022 | 16.09 Mn |
| Dec 31, 2021 | 14.73 Mn |
| Sep 30, 2021 | 11.89 Mn |